Ireland· IE-PA-EU/1/13/892/005-006
Tivicay 25 mg film-coated tablets
A dolutegravir product containing dolutegravir, registered in Ireland by ViiV Healthcare BV.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
The record
At a glance
HPRA (Ireland)- Active substance
- Dolutegravir
- Manufacturer
- ViiV Healthcare BV
- Country
- Ireland (IE)
- ATC code
- J05AX12
- ATC class
- Dolutegravir
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/13/892/005-006
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
94 interactions on record for dolutegravir.
Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dolutegravir · interactions on record
94 records
- 42 severe
- 3 moderate
- 49 minor
Most severe, free to view
- Magnesium carbonateA02AA01severe
- Magnesium oxideA02AA02severe
- Magnesium hydroxideA02AA04severe
- Kombinationen von AluminiumsalzenA02AB10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dolutegravir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenDogrivio 25 mg Filmdragerad tablettElpen Pharmaceutical Co. Inc
- United StatesTivicayViiV Healthcare Company
- CzechiaTIVICAYViiV Healthcare BV, Amersfoort
- FranceTIVICAY 25 mg, comprimé pelliculéVIIV HEALTHCARE (PAYS-BAS)
- BelgiumTivicay 25 mgViiV Healthcare
- NetherlandsTivicay 25 mg, filmomhulde tabletViiV healthcare B.V.
- PolandTivicayViiV Healthcare BV
- IcelandTivicayViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Cyprus · Dogrivio
- Iceland · Tivicay
- Liechtenstein · Tivicay
- Norway · Dolutegravir Teva, Tivicay
- Sweden · Dogrivio, Dolutegravir Elpen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/df9829e6-d362-4764-9eaf-4adeb51faa79 GET /v1/drugs/df9829e6-d362-4764-9eaf-4adeb51faa79?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Film-coated tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"J05AX",
"J05AX12"
],
"strength": null,
"pa_number": "EU/1/13/892/005-006",
"substances": [
"Dolutegravir"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "23/02/2017",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about dolutegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.